Palisade Bio, Inc.

PALI Nasdaq SEC CIK 1357459
Follow Palisade Bio Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $0
Net income −$14.6M −409.9% vs same quarter last year
EPS, diluted −$0.07 +81.6% vs same quarter last year
Operating cash flow −$11.8M −231% vs same quarter last year
Revenue by quarter
$0
$0
$0
$0
$0
$0
$500K
$0
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$30M−$20M−$10M$0$10MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$0−$16.8M
FY24$0−$14.4M
FY23$250K−$12.3M
FY22$0−$14.3M
FY21-−$26.6M
FY20$13.5K−$10.3M
FY19$15.4K−$8.4M
FY18$260K−$4.9M
FY17$260K−$15.7M
FY16$16.2K−$21.1M
FY15$10.4K−$20.9M
FY14$18.8K−$22.6M
FY13$110K−$19.8M
FY12$407.7K−$10.1M
FY11$390.6K−$12.5M
MarginsShare of revenue
  • Operating margin
  • Net margin
−300000%−200000%−100000%0%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearOperating marginNet margin
FY25--
FY24--
FY23−5228%−4920%
FY22--
FY21--
FY20−68764.8%−76346.2%
FY19−56071.8%−54252.6%
FY18−3176.7%−1894.1%
FY17−5118.1%−6025.4%
FY16−127027.2%−129721.8%
FY15−183896.8%−200671%
FY14−92581.4%−120154.7%
FY13−11385.4%−18029%
FY12−2491.1%−2482.5%
FY11−3325.6%−3204.7%
Free cash flowOperating cash flow minus capital expenditure
−$20M−$15M−$10M−$5M$0FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25-
FY24−$12.2M
FY23−$11.1M
FY22−$13.4M
FY21−$14.8M
FY20−$4.8M
FY19-
FY18−$7.7M
FY17−$13.4M
FY16−$15.7M
FY15−$19.1M
FY14−$11.9M
FY13−$10.7M
FY12−$8.5M
FY11−$8.3M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Palisade Bio
  • Healthcare median
−300000%−200000%−100000%0%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearPalisade BioHealthcare median
FY25-−30.6%
FY24-−47%
FY23−4920%−58%
FY22-−80.4%
FY21-−71.8%
FY20−76346.2%−62.2%
FY19−54252.6%−46.2%
FY18−1894.1%−49.6%
FY17−6025.4%−45.9%
FY16−129721.8%−36%
FY15−200671%−37.8%
FY14−120154.7%−35.5%
FY13−18029%−37.1%
FY12−2482.5%−29.1%
FY11−3204.7%−27.9%